“Chemophobia” rampant
This article was originally published in The Rose Sheet
Executive Summary
Consumers' perception of chemicals amounts to "chemophobia" - a fear and distrust of chemicals that is not proportionate to their actual risk, according to Dan Gardner, columnist and senior writer for the Ottawa Citizen and author of the book, "The Science of Fear: Why We Fear Things We Shouldn't - And Put Ourselves in Greater Danger." Speaking at a Feb. 25 session of the Personal Care Products Council's annual meeting in Boca Raton, Fla., Gardner cited a study led by risk assessment researcher Dr. Paul Slovic to gauge the public's perception of chemicals in the U.S., UK and Canada. In the study, 75% of participants in each country said they try to avoid chemicals and would not drink water if it contained "even a tiny amount of a carcinogen," roughly 70% that someone exposed to a carcinogen will probably get cancer, and 60% that it is never too expensive to reduce the risk from chemicals, according to Gardner. Chemophobia "drives up the perception of risk," the journalist said. On the other hand, consumer perception of the term "natural" is "as strongly positive as 'chemical' is negative." Gardner suggested that industry adopt a "capitulate-or-fight" strategy - either go green or band together with other consumer product sectors such as the food industry to offer a response "as big and as deep as the problem.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.